Clinical Trial Update: Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating azithromycin to improve latency in an exam indicated cerclage control trial for preterm birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstetric Labor Complications
• Pregnancy Complications
• Preterm Birth
• Uterine Cervical Incompetence

Drugs mentioned

• Azithromycin (azithromycin)
• CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Preterm Birth, Obstetric Labor, Premature | Phase 4 | Status: UNKNOWN